Ordered biochemical program of gene expression in cancer cells

Biochemistry (Moscow)

Volumn 66, Issue 10, 2001, Pages 1164-1173

  Weber, G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biochemical strategy of the genome; Carbohydrate metabolism; IMP dehydrogenase as target of tiazofurin treatment; Isozyme pattern; Key enzyme concept; Key enzymes; Leukemia treatment by an inhibitor of IMP dehydrogenase; Molecular correlation concept; Purine metabolism imbalance in cancer cells; Pyrimidine metabolism imbalance in cancer cells; Reprogramming of gene expression in cancer cells evidence; Signal transduction; Specificity of neoplastic pattern; Spectrum of tumors of graded malignancy

Indexed keywords

ORNITHINE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL; ANTIBODY SPECIFICITY; DISEASE COURSE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLYCOLYSIS; HUMAN; METABOLISM; MOLECULAR BIOLOGY; NEOPLASM; REVIEW;

ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HUMAN; MOLECULAR BIOLOGY; NEOPLASMS; ORGAN SPECIFICITY; ORNITHINE; PURINES; PYRIMIDINES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035471026     PISSN: 00062979     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012493232344     Document Type: Article

References (20)

1. Severin, S. E., and Feigina, M. M. (1977) Advan. Enzyme Regul., 15, 1-21.
2. Severin, S. E., and Stepanova, N. G. (1981) Advan. Enzyme Regul., 19, 235-255.
3. Severin, S. E., Khailova, L. S., and Gomazkova, V. S. (1986) Advan. Enzyme Regul., 25, 347-375.
4. Weber, G. (1961) Advan. Cancer Res., 6, 403-494.
5. Weber, G. (1977) New Engl. J. Med., 296, 486-493, 541-551.
6. Weber, G. (1983) Cancer Res., 43, 3466-3492.
7. Popper, K. R. (1968) in The Logic of Scientific Discovery, Harper and Row, New York, p. 40.
8. Burnett, F. M. (1970) in Immunological Surveillance, Pergamon Press, New York, p. 127.
9. Medawar, P. B. (1969) in Induction and Intuition in Scientific Thought, Methuen and Co., London, p. 51.
10. Weber, G., and Cantero, A. (1955) Cancer Res., 15, 105-108.
11. Warburg, O. (1956) Science, 123, 309-314.
12. Weinhouse, S. (1972) Cancer Res., 32, 2007-2016.
13. Weber, G. (1980) in Renal Adenocarcinoma (Sufrin, G., and Beckley, S. A., eds.) Geneva, pp. 44-50.
14. Weber, G., Burt, M. E., Jackson, R. C., Prajda, N., Lui, M. S., and Takeda, E. (1983) Cancer Res., 43, 1019-1023.
15. Weber, G., Hager, J. C., Lui, M. S., Prajda, N., Tzeng, D. Y., Jackson, R. C., Takeda, E., and Eble, J. N. (1981) Cancer Res., 41, 854-859.
16. Weber, G., Lui, M. S., Takeda, E., and Denton, J. E. (1980) Life Sci., 27, 793-799.
17. Williams-Ashman, H. G., Coppoc, G. L., and Weber, G. (1972) Cancer Res., 32, 1924-1932.
18. Weber, G., Trevisani, A., and Heinrich, P. C. (1974) Advan. Enzyme Regul., 12, 11-41.
19. Weber, G., Shen, F., Yang, H., Prajda, N., and Li, W. (1999) Advan. Enzyme Regul., 39, 51-66.
20. Tricot, G., Jayaram, H. N., Weber, G., and Hoffman, R. (1990) Intl. J. Cell Cloning, 8, 161-170.